Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Bufei Yishen granule
Henan University of Traditional Chinese Medicine
Chronic Obstructive Pulmonary Disease
1 trial -
GV-971
Shanghai University of Traditional Chinese Medicine
Alzheimer Disease
1 trial -
JS001
Shanghai University of Traditional Chinese Medicine
Triple-Negative Breast Cancer
1 trial -
Loperamide
Chengdu University of Traditional Chinese Medicine
Diarrhea-predominant Irritable Bowel Syndrome
1 trial -
Sodium Thiosulfate Injection
Shanghai University of Traditional Chinese Medicine
Hepatoblastoma
1 trial -
Traditional Chinese Medicine Prescription
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
AK0529
Shanghai University of Traditional Chinese Medicine
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS
1 trial -
EMB-01
Shanghai University of Traditional Chinese Medicine
Neoplasms
1 trial -
Furmonertinib
Shanghai University of Traditional Chinese Medicine
Lung Adenocarcinoma Stage III
1 trial -
JMT108
Shanghai University of Traditional Chinese Medicine
Unresectable Locally Advanced or Metastatic Melanoma
1 trial -
MRG003
Shanghai University of Traditional Chinese Medicine
Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck
1 trial -
SR419
Shanghai University of Traditional Chinese Medicine
Peripheral Neuropathic Pain
1 trial -
TQC2731 injection
Shanghai University of Traditional Chinese Medicine
Chronic Obstructive Pulmonary Disease
1 trial -
TQH2722 injection
Shanghai University of Traditional Chinese Medicine
Seasonal Allergic Rhinitis
1 trial -
Traditional Chinese acupuncture
The University of Hong Kong
Phonotraumatic Injuries
1 trial -
Traditional fabricated prosthetic socket
United Therapeutics Europe Ltd
Amputation
1 trial -
cis Platinum/Carboplatin, Pemetrexed Disodium
Shanghai University of Traditional Chinese Medicine
Chemotherapy, Adjuvant
1 trial -
9MW3811 injection
Shanghai University of Traditional Chinese Medicine
Pulmonary Fibrosis
1 trial -
Donepezil Dihydroxynaphthalate for Injection
Shanghai University of Traditional Chinese Medicine
Alzheimer Disease
1 trial -
HB0056
Shanghai University of Traditional Chinese Medicine
Healthy
1 trial -
JWCAR029 (CD19-targeted Chimeric Antigen Receptor Cells)
Shanghai University of Traditional Chinese Medicine
Diffuse Large B Cell Lymphoma
1 trial -
MWN109 tablet
Shanghai University of Traditional Chinese Medicine
Overweight or Obesity
1 trial -
Qing'E pill
Shanghai University of Traditional Chinese Medicine
Menopause
1 trial -
Recombinant Humanized Anti-IL-36R Monoclonal antibody and Placebo
Shanghai University of Traditional Chinese Medicine
Healthy
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources